Our IBM Collaboration & HOYA Distributorship

June 1, 2016

Dear Eye Care Professional:

We recently announced our plans to collaborate with IBM to develop a first-of-its-kind Apple iPhone and iPad app for cataract surgeons. Designed to help streamline your workflow, the app will deliver patient information and clinical insights as well as intraocular lens (IOL) options on a single, digital platform at the point of care.

Technology continues to impact almost every facet of our lives, and when we considered the mobile solutions available today, and how technology can help to improve the quality of care, we knew we identified an area of major need in ophthalmology.  We believe that bringing a much-needed mobile solution to cataract surgeons can not only help improve efficiencies for you, but also help deliver excellent surgical outcomes for your patients. The app will allow you to access all of a patient’s surgical information in one place and to receive intuitive feedback for IOL selection.  Our vision is to help improve your procedures while driving greater efficiencies in managing patient flow; an incredible benefit for you and your practice.

In addition to our partnership with IBM, we’re excited to share with you some more immediate additions to our portfolio. As announced last month, Bausch + Lomb has entered an exclusive agreement with HOYA Surgical Optics to distribute and commercialize HOYA’s comprehensive portfolio of intraocular lenses (IOLs) and injectors in the U.S.

As the worldwide leader in preloaded IOL delivery systems with over four million preloaded systems used to date, HOYA’s offerings will be combined with our surgical platforms and technologies to provide you with multiple product options to help deliver the best possible surgical outcomes for your patients. HOYA and Bausch + Lomb are also co-developing a new pre-loaded IOL platform offering a new aspheric optic design. Your Bausch + Lomb sales representative will be in touch over the next few months to provide you additional information and updates.

In response to the growing trend toward advanced anterior vitrectomy techniques, we just launched a small gauge vitrectomy package for the Stellaris® microsurgical system that combines essential components for 23 gauge and 25 gauge anterior vitrectomy. This allows surgeons to perform anterior vitrectomy at their own preferred incision size either anteriorly through a corneal incision or using a pars plana approach with the respective ESA cannula.

These exciting developments are just a few examples of our continued commitment to delivering innovative, state-of-the-art products for you, your patients, and the ophthalmic industry.  This is made possible with your support and partnership, which we deeply appreciate.  

We look forward to sharing more news with you in the near future.  In the meantime, reach out to me with any questions, comments or ideas at
Andrew.Chang@bausch.com – we’d love to hear from you.

Best regards,


Andrew Chang                                                                                            

General Manager and Senior Vice President                                                      
U.S. Surgical, Bausch + Lomb